Back to Search
ANNE-CATRIN UHLEMANN, MD
MD
Infectious Disease Physician
NPI: 1386801785IndividualAccepts Medicare
Specialties, Licenses & Credentials
General Acute Care Hospital
General Acute Care Hospital
Code: 282N00000X
60-250178(NY)
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
250178(NY)
Education
OTHER
Class of 1999
Research & Publications (20)
DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria.
PMID 15181570·J Infect Dis·2004
7-preclinical
Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii.
PMID 11704272·Mol Biochem Parasitol·2001
7-preclinical
Inhibition of CD95/Fas-induced DNA degradation by osmotic cell shrinkage.
PMID 11093032·Cell Physiol Biochem·2000
8-other
Effect of artemisinins and amino alcohol partner antimalarials on mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase activity.
PMID 18684232·Basic Clin Pharmacol Toxicol·2008
7-preclinical
The Fe2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediates.
PMID 17768732·ChemMedChem·2007
7-preclinical
Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro.
PMID 17280676·Int J Parasitol·2007
7-preclinical
Genome variation and evolution of the malaria parasite Plasmodium falciparum.
PMID 17159978·Nat Genet·2007
4-observational
Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand.
PMID 17152017·J Infect Dis·2007
7-preclinical
Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277).
PMID 17145800·Antimicrob Agents Chemother·2007
4-observational
Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites.
PMID 17124182·Mol Biol Evol·2007
7-preclinical
A promoter polymorphism in the interferon alpha-2 gene is associated with the clinical presentation of hepatitis B.
PMID 16920161·Mutat Res·2006
8-other
Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.
PMID 16845638·J Infect Dis·2006
7-preclinical
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.
PMID 16652314·Clin Infect Dis·2006
3-trial
Antimalarial multi-drug resistance in Asia: mechanisms and assessment.
PMID 16265886·Curr Top Microbiol Immunol·2005
6-review
Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon.
PMID 16235185·J Infect Dis·2005
2-rct
A single amino acid residue can determine the sensitivity of SERCAs to artemisinins.
PMID 15937493·Nat Struct Mol Biol·2005
4-observational
Characterisation of a tryptophan-rich Plasmodium falciparum antigen associated with merozoites.
PMID 15383306·Mol Biochem Parasitol·2004
7-preclinical
Recombinant Duffy binding-like-alpha domains of Plasmodium falciparum erythrocyte membrane protein 1 elicit antibodies in rats that recognise conserved epitopes.
PMID 12802682·Parasitol Res·2003
7-preclinical
Transport processes in Plasmodium falciparum-infected erythrocytes: potential as new drug targets.
PMID 12435441·Int J Parasitol·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 622 W 168TH ST, DEPARTMENT OF PULMONARY AND CRITICAL CARE, PH-8
NEW YORK, NY 10032 - Phone
- (212) 305-2323
Quick Facts
- NPI
- 1386801785
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile